These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9305410)

  • 21. Behavioural pharmacology of the new generation of antipsychotic agents.
    Moore NA
    Br J Psychiatry Suppl; 1999; (38):5-11. PubMed ID: 10884895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical antipsychotic drugs and long-term outcome in schizophrenia.
    Weiden P; Aquila R; Standard J
    J Clin Psychiatry; 1996; 57 Suppl 11():53-60. PubMed ID: 8941171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Atypical antipsychotic drugs].
    Kahn RS
    Ned Tijdschr Geneeskd; 2000 Aug; 144(34):1627-30. PubMed ID: 10972052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
    Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
    Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.
    Miyamoto S; Duncan GE; Marx CE; Lieberman JA
    Mol Psychiatry; 2005 Jan; 10(1):79-104. PubMed ID: 15289815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY; Li Z; Kaneda Y; Ichikawa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What's atypical about atypical antipsychotic drugs?
    Meltzer HY
    Curr Opin Pharmacol; 2004 Feb; 4(1):53-7. PubMed ID: 15018839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D2 antagonist augmentation in patients with a partial response to atypical antipsychotics.
    Mazeh D; Melamed Y; Weizman A
    Can J Psychiatry; 2004 Apr; 49(4):281-2. PubMed ID: 15147030
    [No Abstract]   [Full Text] [Related]  

  • 29. Evolution of schizophrenia drugs: a focus on dopaminergic systems.
    Nikam SS; Awasthi AK
    Curr Opin Investig Drugs; 2008 Jan; 9(1):37-46. PubMed ID: 18183530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into the biology of schizophrenia through the mechanism of action of clozapine.
    Brunello N; Masotto C; Steardo L; Markstein R; Racagni G
    Neuropsychopharmacology; 1995 Nov; 13(3):177-213. PubMed ID: 8602893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New antipsychotic medications: what advantages do they offer?
    Citrome L
    Postgrad Med; 1997 Feb; 101(2):207-10, 213-4. PubMed ID: 9046936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schizophrenia treatment. Critical review on the drugs and mechanisms of action of antipsychotics.
    Tajima K; Fernández H; López-Ibor JL; Carrasco JL; Díaz-Marsá M
    Actas Esp Psiquiatr; 2009; 37(6):330-42. PubMed ID: 20066585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine vs. other atypical antipsychotics for schizophrenia.
    Kripke C
    Am Fam Physician; 2011 Feb; 83(3):260-1. PubMed ID: 21302867
    [No Abstract]   [Full Text] [Related]  

  • 34. Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.
    Lieberman JA; Bymaster FP; Meltzer HY; Deutch AY; Duncan GE; Marx CE; Aprille JR; Dwyer DS; Li XM; Mahadik SP; Duman RS; Porter JH; Modica-Napolitano JS; Newton SS; Csernansky JG
    Pharmacol Rev; 2008 Sep; 60(3):358-403. PubMed ID: 18922967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipsychotic treatment in schizophrenia: atypical options and NICE guidance.
    Mortimer AM
    Eur Psychiatry; 2003 Aug; 18(5):209-19. PubMed ID: 12927321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Theory in antipsychotic drug therapy for schizophrenia].
    Tomioka S; Ishigooka J
    Seishin Shinkeigaku Zasshi; 2006; 108(6):614-8. PubMed ID: 16910539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of antipsychotic D2 antagonists on long-term potentiation in animals and implications for human studies.
    Price R; Salavati B; Graff-Guerrero A; Blumberger DM; Mulsant BH; Daskalakis ZJ; Rajji TK
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():83-91. PubMed ID: 24819820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials.
    Stahl SM
    J Clin Psychiatry; 1999; 60 Suppl 10():31-41. PubMed ID: 10340685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Switching antipsychotic medications.
    Weiden PJ; Aquila R; Dalheim L; Standard JM
    J Clin Psychiatry; 1997; 58 Suppl 10():63-72. PubMed ID: 9265919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amisulpride a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials.
    Leucht S
    Int J Neuropsychopharmacol; 2004 Mar; 7 Suppl 1():S15-20. PubMed ID: 14972080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.